A detailed history of Sumitomo Mitsui Trust Holdings, Inc. transactions in Teva Pharmaceutical Industries LTD stock. As of the latest transaction made, Sumitomo Mitsui Trust Holdings, Inc. holds 1,974,106 shares of TEVA stock, worth $35.3 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares
1,974,106
Previous 2,159,333 8.58%
Holding current value
$35.3 Million
Previous $30.5 Million 5.29%
% of portfolio
0.02%
Previous 0.02%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 19, 2024

SELL
$12.78 - $17.4 $2.37 Million - $3.22 Million
-185,227 Reduced 8.58%
1,974,106 $32.1 Million
Q1 2024

Apr 19, 2024

BUY
$10.67 - $14.43 $295,697 - $399,898
27,713 Added 1.3%
2,159,333 $30.5 Million
Q4 2023

Jan 30, 2024

SELL
$8.12 - $10.63 $103,578 - $135,596
-12,756 Reduced 0.59%
2,131,620 $22.3 Million
Q3 2023

Oct 30, 2023

SELL
$7.48 - $10.7 $97,995 - $140,180
-13,101 Reduced 0.61%
2,144,376 $21.9 Million
Q2 2023

Jul 31, 2023

SELL
$7.2 - $9.47 $3.45 Million - $4.54 Million
-478,893 Reduced 18.16%
2,157,477 $16.2 Million
Q1 2023

Apr 27, 2023

SELL
$8.36 - $11.37 $83,616 - $113,722
-10,002 Reduced 0.38%
2,636,370 $23.3 Million
Q4 2022

Jan 30, 2023

SELL
$7.95 - $9.48 $240,503 - $286,788
-30,252 Reduced 1.13%
2,646,372 $24.1 Million
Q3 2022

Oct 21, 2022

SELL
$6.86 - $11.95 $106,576 - $185,655
-15,536 Reduced 0.58%
2,676,624 $21.6 Million
Q2 2022

Jul 26, 2022

BUY
$7.38 - $10.4 $1.09 Million - $1.54 Million
148,351 Added 5.83%
2,692,160 $20.2 Million
Q1 2022

Apr 27, 2022

BUY
$7.33 - $9.39 $115,835 - $148,390
15,803 Added 0.63%
2,543,809 $23.9 Million
Q4 2021

Feb 02, 2022

SELL
$7.9 - $10.19 $1.57 Million - $2.02 Million
-198,537 Reduced 7.28%
2,528,006 $20.2 Million
Q3 2021

Oct 25, 2021

SELL
$8.38 - $10.18 $544,222 - $661,119
-64,943 Reduced 2.33%
2,726,543 $26.6 Million
Q2 2021

Aug 02, 2021

SELL
$9.9 - $11.56 $1.4 Million - $1.64 Million
-141,480 Reduced 4.82%
2,791,486 $27.6 Million
Q1 2021

Apr 30, 2021

SELL
$10.34 - $12.81 $1.97 Million - $2.44 Million
-190,557 Reduced 6.1%
2,932,966 $33.8 Million
Q4 2020

Feb 05, 2021

SELL
$8.61 - $11.04 $4.56 Million - $5.85 Million
-529,566 Reduced 14.5%
3,123,523 $30.1 Million
Q3 2020

Oct 30, 2020

SELL
$8.57 - $12.69 $4.12 Million - $6.1 Million
-480,944 Reduced 11.63%
3,653,089 $32.9 Million
Q2 2020

Jul 27, 2020

SELL
$8.12 - $13.12 $556,544 - $899,244
-68,540 Reduced 1.63%
4,134,033 $51 Million
Q1 2020

Apr 27, 2020

BUY
$6.69 - $13.45 $1.04 Million - $2.09 Million
155,728 Added 3.85%
4,202,573 $37.7 Million
Q4 2019

Jan 31, 2020

BUY
$6.53 - $10.72 $395,404 - $649,117
60,552 Added 1.52%
4,046,845 $39.7 Million
Q3 2019

Oct 31, 2019

SELL
$6.16 - $9.6 $115,690 - $180,297
-18,781 Reduced 0.47%
3,986,293 $27.4 Million
Q2 2019

Jul 29, 2019

BUY
$8.12 - $15.72 $3.73 Million - $7.21 Million
458,751 Added 12.94%
4,005,074 $37 Million
Q1 2019

May 08, 2019

SELL
$15.58 - $20.01 $630,896 - $810,284
-40,494 Reduced 1.13%
3,546,323 $55.6 Million
Q4 2018

Feb 06, 2019

BUY
$14.59 - $23.84 $8.4 Million - $13.7 Million
575,709 Added 19.12%
3,586,817 $56.3 Million
Q3 2018

Nov 07, 2018

BUY
$21.06 - $25.65 $416,271 - $506,997
19,766 Added 0.66%
3,011,108 $64.9 Million
Q2 2018

Aug 01, 2018

BUY
$16.77 - $24.71 $4.84 Million - $7.13 Million
288,406 Added 10.67%
2,991,342 $72.7 Million
Q1 2018

May 01, 2018

BUY
$16.68 - $22.07 $97,911 - $129,550
5,870 Added 0.22%
2,702,936 $46.2 Million
Q4 2017

Feb 06, 2018

BUY
$11.23 - $19.1 $585,577 - $995,950
52,144 Added 1.97%
2,697,066 $51.1 Million
Q3 2017

Nov 07, 2017

SELL
$15.41 - $32.17 $549,212 - $1.15 Million
-35,640 Reduced 1.33%
2,644,922 $46.6 Million
Q2 2017

Aug 07, 2017

BUY
N/A
2,680,562
2,680,562 $89 Million

Others Institutions Holding TEVA

About TEVA PHARMACEUTICAL INDUSTRIES LTD


  • Ticker TEVA
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 1,110,560,000
  • Market Cap $19.8B
  • Description
  • Teva Pharmaceutical Industries Limited, a pharmaceutical company, develops, manufactures, markets, and distributes generic medicines, specialty medicines, and biopharmaceutical products in North America, Europe, and internationally. The company offers sterile products, hormones, high-potency drugs, and cytotoxic substances in various dosage form...
More about TEVA
Track This Portfolio

Track Sumitomo Mitsui Trust Holdings, Inc. Portfolio

Follow Sumitomo Mitsui Trust Holdings, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Sumitomo Mitsui Trust Holdings, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Sumitomo Mitsui Trust Holdings, Inc. with notifications on news.